Interventricular mechanical dyssynchrony determines abnormal heightening of plasma N-terminal probrain natriuretic peptide level in symptomatic bradyarrhythmia patients with chronic dual-chamber vs. single-chamber atrial pacing

Cardiology

Volumn 110, Issue 3, 2008, Pages 167-173

  Lin, Jih Min ^b   Lai, Ling Ping ^a   Tsai, Chia Ti ^a   Lin, Lung Chun ^a   Tseng, Chuen Den ^a   Lin, Jiunn Lee ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KEELUNG HOSPITAL   (Taiwan)

Author keywords

Brain natriuretic peptide; Mechanical dyssynchrony; Permanent pacemaker

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART VENTRICLE CONTRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS NODE DYSFUNCTION;

ADULT; AGED; AGED, 80 AND OVER; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SICK SINUS SYNDROME; VENTRICULAR DYSFUNCTION;

EID: 44849112941     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111926     Document Type: Article

References (18)

1. Rosenqvist M, Isaaz K, Botvinick EH, Dae MW, Cockrell J, Abbott JA, Schiller NB, Griffin JC: Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. Am J Cardiol 1991;67:148-156.
2. Lee MA, Dae MW, Langberg JJ, Griffin JC, Chin MC, Finkbeiner WE, O'Connell JW, Botvinick E, Scheinman MM, Rosenqvist M: Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 1994;24:225-232.
3. Taylor JA, Morillo CA, Eckberg DL, Ellenbogen KA: Higher sympathetic nerve activity during ventricular (VVI) than during dual-chamber (DDD) pacing. J Am Coll Cardiol 1996;28:1753-1758.
4. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK: Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997;350:1210-1216.
5. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385-1391.
6. Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK: A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. J Am Coll Cardiol 2003;42:614-623.
7. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Tee R, Marinchak RS, Flaker G, Schron E, Orav EJ, Mellkamp AS, Goldman L, for the MOST Investigators: Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med 2002;346:1854-1862.
8. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA; MOde Selection Trial Investigators: Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-2937.
9. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123.
10. Weber M, Hamm C: Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006;92:843-849.
11. Bader H, Garrigue S, Lafitte S, Reuter S, Jais P, Haissaguerre M, Bonnet J, Clementy J, Roudaut R: Intra-left ventricular electromechanical asynchrony: a new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43:248-256.
12. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB: The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948-954.
13. Thackray SDR, Witte K, Ghosh J, Nikitin N, Anderson A, Rigby A, Goode K, Clark AL, Clelan JGF: N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population. Eur Heart J 2006;27:447-453.
14. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, Estes NA 3rd, Mitchell GF, Lieberman EH, Mangione CM, Goldman L; the Pacemaker Selection in the Elderly Investigators: Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing: Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998;338:1097-1104.
15. Toff WD, Camm AJ, Skehan JD, the United Kingdom Pacing and Cardiovascular Events (UKPACE) trial investigators: Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145-155.
16. Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, Lee KL, Skene AM, Schron EB, Skehan JD, Goldman L, Roberts RS, Camm AJ, Yusuf S, Connolly SJ: Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 2006;114:11-17.
17. Sweeney MO, Hellkamp AS: Heart failure during cardiac pacing. Circulation 2006;113:2082-2088.
18. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-982.